{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:27:24Z","timestamp":1761708444517,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jaad.2009.03.021","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T05:09:32Z","timestamp":1260940172000},"page":"164-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C"],"prefix":"10.1016","volume":"62","author":[{"given":"Dina","family":"Farshidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin W.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.03.021_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2133.2003.05422.x","article-title":"Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection","volume":"149","author":"Willems","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.021_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1572-0241.2005.00323.x","article-title":"Tongue and skin hyperpigmentation during PEG-interferon-alpha\/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C","volume":"101","author":"Gurguta","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.03.021_bib3","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1572-0241.2007.01162.x","article-title":"Tongue hyperpigmentation in a Caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy","volume":"102","author":"Torres","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.03.021_bib4","first-page":"324","article-title":"Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C","volume":"25","author":"Sood","year":"2006","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.03.021_bib5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gut.2008.160184","article-title":"A surprising hyperpigmentation of the gums and tongue","volume":"57","author":"Dell'Isola","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2009.03.021_bib6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1468-3083.2008.02653.x","article-title":"Tongue hyperpigmentation resulting from peginterferon alpha-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C","volume":"22","author":"Fernandez","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209003612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209003612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:14:42Z","timestamp":1759270482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209003612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0190962209003612"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.03.021","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}